Torrey Pines Medicine: Pre-SeedDevelops ultra-long-acting peptide therapeutics for obesity, diabetes, and metabolic diseasesOct 4, 2026RoundOSTorrey Pines MedicineCompany profile and funding historySourcesprnewswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechChinaEnterprise softwareHealthtechPre-seedAsia